The IPO Buzz: ELYM Leaps, SSBK Gains & FINW Postponed
(Editor’s Note: This column was updated Thursday afternoon with the postponement of FinWise Bancorp and the closing price of Southern States Bancshares on its first day of trading.) Eliem Therapeutics (ELYM) jumped on Tuesday in its NASDAQ debut, opening at $16.25 – up 30 percent from its $12.50 IPO price. The biotech trimmed its IPO’s price to […]
August 9, 2021 Read More